About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2010 (2010), Article ID 562051, 11 pages
http://dx.doi.org/10.1155/2010/562051
Review Article

What We Know and Do Not Know about Sex and Cardiac Disease

Department of Physiology, Molecular Cardiovascular Research Program, Sarver Heart Center, University of Arizona, 1656 E Mabel, Medical Research Building, Room 320, Tucson, AZ 85724, USA

Received 1 December 2009; Accepted 16 February 2010

Academic Editor: Henk L. M. Granzier

Copyright © 2010 John P. Konhilas. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. V. Villar, M. Llano, M. Cobo, et al., “Gender differences of echocardiographic and gene expression patterns in human pressure overload left ventricular hypertrophy,” Journal of Molecular and Cellular Cardiology, vol. 46, no. 4, pp. 526–535, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Villari, S. E. Campbell, J. Schneider, G. Vassalli, M. Chiariello, and O. M. Hess, “Sex-dependent differences in left ventricular function and structure in chronic pressure overload,” European Heart Journal, vol. 16, no. 10, pp. 1410–1419, 1995. View at Scopus
  3. P. P. Dimitrow, D. Czarnecka, K. Kawecka-Jaszcz, and J. S. Dubiel, “The influence of age on gender-specific differences in the left ventricular cavity size and contractility in patients with hypertrophic cardiomyopathy,” International Journal of Cardiology, vol. 88, no. 1, pp. 11–16, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. R. De Maria, A. Gavazzi, F. Recalcati, G. Baroldi, C. De Vita, and F. Camerini, “Comparison of clinical findings in idiopathic dilated cardiomyopathy in women versus men,” American Journal of Cardiology, vol. 72, no. 7, pp. 580–585, 1993. View at Publisher · View at Google Scholar · View at Scopus
  5. P. S. Douglas, S. E. Katz, E. O. Weinberg, M. H. Chen, S. P. Bishop, and B. H. Lorell, “Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload,” Journal of the American College of Cardiology, vol. 32, no. 4, pp. 1118–1125, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Deswal and B. Bozkurt, “Comparison of morbidity in women versus men with heart failure and preserved ejection fraction,” American Journal of Cardiology, vol. 97, no. 8, pp. 1228–1231, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. D. D. Schocken, M. I. Arrieta, P. E. Leaverton, and E. A. Ross, “Prevalence and mortality rate of congestive heart failure in the United States,” Journal of the American College of Cardiology, vol. 20, no. 2, pp. 301–306, 1992. View at Scopus
  8. C. A. Martin, P. L. Thompson, B. K. Armstrong, M. S. Hobbs, and N. de Klerk, “Long-term prognosis after recovery from myocardial infarction: a nine year follow-up of the Perth Coronary Register,” Circulation, vol. 68, no. 5, pp. 961–969, 1983.
  9. V. Vaccarino, L. Parsons, N. R. Every, H. V. Barron, and H. M. Krumholz, “Sex-based differences in early mortality after myocardial infarction,” New England Journal of Medicine, vol. 341, no. 4, pp. 217–225, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. J. E. Rossouw, G. L. Anderson, R. L. Prentice, et al., “Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial,” Journal of the American Medical Association, vol. 288, no. 3, pp. 321–333, 2002. View at Scopus
  11. J. P. Konhilas and L. A. Leinwand, “The effects of biological sex and diet on the development of heart failure,” Circulation, vol. 116, no. 23, pp. 2747–2759, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. K. M. Dale, C. I. Coleman, S. A. Shah, A. A. Patel, J. Kluger, and C. M. White, “Impact of gender on statin efficacy,” Current Medical Research and Opinion, vol. 23, no. 3, pp. 565–574, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. R. H. Knopp and B. M. Retzlaff, “Saturated fat prevents coronary artery disease? An American paradox,” American Journal of Clinical Nutrition, vol. 80, no. 5, pp. 1102–1103, 2004. View at Scopus
  14. B. Mittendorfer, “Sexual dimorphism in human lipid metabolism,” Journal of Nutrition, vol. 135, no. 4, pp. 681–686, 2005. View at Scopus
  15. B. Mittendorfer, B. W. Patterson, and S. Klein, “Effect of sex and obesity on basal VLDL-triacylglycerol kinetics,” American Journal of Clinical Nutrition, vol. 77, no. 3, pp. 573–579, 2003. View at Scopus
  16. P. Cullen, “Evidence that triglycerides are an independent coronary heart disease risk factor,” American Journal of Cardiology, vol. 86, no. 9, pp. 943–949, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. J. C. LaRosa, “Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?” Women's Health Issues, vol. 2, no. 2, pp. 102–113, 1992. View at Scopus
  18. T. L. Bush, L. P. Fried, and E. Barrett-Connor, “Cholesterol, lipoproteins, and coronary heart disease in women,” Clinical Chemistry, vol. 34, no. 8, pp. B60–B70, 1988. View at Scopus
  19. E. M. Hsich and I. L. Piña, “Heart failure in women. A need for prospective data,” Journal of the American College of Cardiology, vol. 54, no. 6, pp. 491–498, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Lloyd-Jones, R. Adams, M. Carnethon, et al., “Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee,” Circulation, vol. 119, no. 3, pp. e21–e181, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. G. S. Bleumink, A. M. Knetsch, M. C. J. M. Sturkenboom, et al., “Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure—the Rotterdam Study,” European Heart Journal, vol. 25, no. 18, pp. 1614–1619, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Hofman, D. E. Grobbee, P. T. V. M. de Jong, and F. A. van den Ouweland, “Determinants of disease and disability in the elderly: the Rotterdam Elderly Study,” European Journal of Epidemiology, vol. 7, no. 4, pp. 403–422, 1991. View at Scopus
  23. H. Ni, “Prevalence of self-reported heart failure among US adults: results from the 1999 National Health Interview Survey,” American Heart Journal, vol. 146, no. 1, pp. 121–128, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. S. B. Mohan, M. Parker, M. Wehbi, and P. Douglass, “Idiopathic dilated cardiomyopathy: a common but mystifying cause of heart failure,” Cleveland Clinic Journal of Medicine, vol. 69, no. 6, pp. 481–487, 2002. View at Scopus
  25. Q. Ciampi and B. Villari, “Role of echocardiography in diagnosis and risk stratification in heart failure with left ventricular systolic dysfunction,” Cardiovascular Ultrasound, vol. 5, article 34, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Marmor and A. Schneeweiss, “Prognostic value of noninvasively obtained left ventricular contractile reserve in patients with severe heart failure,” Journal of the American College of Cardiology, vol. 29, no. 2, pp. 422–428, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Alla, A. Y. Al-Hindi, C. R. Lee, T. A. Schwartz, J. H. Patterson, and K. F. Adams Jr., “Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction,” American Heart Journal, vol. 153, no. 6, pp. 1074–1080, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. M. Redfield, S. J. Jacobsen, J. C. Burnett, D. W. Mahoney, K. R. Bailey, and R. J. Rodeheffer, “Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic,” Journal of the American Medical Association, vol. 289, no. 2, pp. 194–202, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. R. S. Vasan, M. G. Larson, E. J. Benjamin, J. C. Evans, C. K. Reiss, and D. Levy, “Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort,” Journal of the American College of Cardiology, vol. 33, no. 7, pp. 1948–1955, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. R. S. Bhatia, J. V. Tu, D. S. Lee, et al., “Outcome of heart failure with preserved ejection fraction in a population-based study,” New England Journal of Medicine, vol. 355, no. 3, pp. 260–269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. T. E. Owan, D. O. Hodge, R. M. Herges, S. J. Jacobsen, V. L. Roger, and M. M. Redfield, “Trends in prevalence and outcome of heart failure with preserved ejection fraction,” New England Journal of Medicine, vol. 355, no. 3, pp. 251–259, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. M. R. Cowie, A. Mosterd, D. A. Wood, et al., “The epidemiology of heart failure,” European Heart Journal, vol. 18, no. 2, pp. 208–225, 1997. View at Scopus
  33. C. Tschöpe and D. Westermann, “Heart failure with normal ejection fraction. Pathophysiology, diagnosis, and treatment,” Herz, vol. 34, no. 2, pp. 89–96, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. G. P. Aurigemma, “Diastolic heart failure—a common and lethal condition by any name,” New England Journal of Medicine, vol. 355, no. 3, pp. 308–310, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Borbély, I. Falcao-Pires, L. van Heerebeek, et al., “Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium,” Circulation Research, vol. 104, no. 6, pp. 780–786, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Borbély, Z. Papp, I. Édes, and W. J. Paulus, “Molecular determinants of heart failure with normal left ventricular ejection fraction,” Pharmacological Reports, vol. 61, no. 1, pp. 139–145, 2009. View at Scopus
  37. M. H. Radke, J. Peng, Y. Wu, et al., “Targeted deletion of titin N2B region leads to diastolic dysfunction and cardiac atrophy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 9, pp. 3444–3449, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. V. S. Castanho, L. S. Oliveira, H. P. Pinheiro, H. C. Oliveira, and E. C. de Faria, “Sex differences in risk factors for coronary heart disease: a study in a Brazilian population,” BMC Public Health, vol. 1, no. 1, article 3, 2001. View at Scopus
  39. Z. Li, J. D. Otvos, S. Lamon-Fava, et al., “Men and women differ in lipoprotein response to dietary saturated fat and cholesterol restriction,” Journal of Nutrition, vol. 133, no. 11, pp. 3428–3433, 2003. View at Scopus
  40. R. A. Hayward, T. P. Hofer, and S. Vijan, “Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem,” Annals of Internal Medicine, vol. 145, no. 7, pp. 520–530, 2006. View at Scopus
  41. R. S. Vasan, M. G. Larson, D. Levy, J. C. Evans, and E. J. Benjamin, “Distribution and categorization of echocardiographic measurements in relation to reference limits: the Framingham Heart Study: formulation of a height- and sex-specific classification and its prospective validation,” Circulation, vol. 96, no. 6, pp. 1863–1873, 1997. View at Scopus
  42. J. P. Konhilas, A. H. Maass, S. W. Luckey, B. L. Stauffer, E. N. Olson, and L. A. Leinwand, “Sex modifies exercise and cardiac adaptation in mice,” American Journal of Physiology, vol. 287, no. 6, pp. H2768–H2776, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. B. L. Stauffer, J. P. Konhilas, E. D. Luczak, and L. A. Leinwand, “Soy diet worsens heart disease in mice,” Journal of Clinical Investigation, vol. 116, no. 1, pp. 209–216, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. E. D. Luczak and L. A. Leinwand, “Sex-based cardiac physiology,” Annual Review of Physiology, vol. 71, pp. 1–18, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. G. de Simone, R. B. Devereux, S. R. Daniels, and R. A. Meyer, “Gender differences in left ventricular growth,” Hypertension, vol. 26, no. 6, pp. 979–983, 1995. View at Scopus
  46. G. Olivetti, G. Giordano, D. Corradi, et al., “Gender differences and aging: effects on the human heart,” Journal of the American College of Cardiology, vol. 26, no. 4, pp. 1068–1079, 1995. View at Publisher · View at Google Scholar · View at Scopus
  47. V. H. Huxley, “Sex and the cardiovascular system: the intriguing tale of how women and men regulate cardiovascular function differently,” American Journal of Physiology, vol. 31, no. 1, pp. 17–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. P. A. Cain, R. Ahl, E. Hedstrom, et al., “Age and gender specific normal values of left ventricular mass, volume and function for gradient echo magnetic resonance imaging: a cross sectional study,” BMC Medical Imaging, vol. 9, article 2, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. C. J. Salton, M. L. Chuang, C. J. O'Donnell, et al., “Gender differences and normal left ventricular anatomy in an adult population free of hypertension: a cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort,” Journal of the American College of Cardiology, vol. 39, no. 6, pp. 1055–1060, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. K. M. Shioura, D. L. Geenen, and P. H. Goldspink, “Sex-related changes in cardiac function following myocardial infarction in mice,” American Journal of Physiology, vol. 295, no. 2, pp. R528–R534, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Suga, “Left ventricular time-varying pressure-volume ratio in systole as an index of myocardial inotropism,” Japanese Heart Journal, vol. 12, no. 2, pp. 153–160, 1971. View at Scopus
  52. K. Sagawa, L. Maughan, H. Suga, and K. Sunagawa, Cardiac Contraction and the Pressure-Volume Relationship, Oxford University Press, New York, NY, USA, 1988.
  53. D. Georgakopoulos and D. A. Kass, “Minimal force-frequency modulation of inotropy and relaxation of in situ murine heart,” Journal of Physiology, vol. 534, no. 2, pp. 535–545, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. E. B. Lankford, D. A. Kass, W. L. Maughan, and A. A. Shoukas, “Does volume catheter parallel conductance vary during a cardiac cycle?” American Journal of Physiology, vol. 258, no. 6, pp. H1933–H1942, 1990. View at Scopus
  55. M. Tomita, F. G. Spinale, F. A. Crawford, and M. R. Zile, “Changes in left ventricular volume, mass, and function during the development and regression of supraventricular tachycardia-induced cardiomyopathy. Disparity between recovery of systolic versus diastolic function,” Circulation, vol. 83, no. 2, pp. 635–644, 1991. View at Scopus
  56. R. Kato, M. Yokota, H. Ishihara, and T. Sobue, “Correlation between left ventricular contractility and relaxation in patients with idiopathic dilated cardiomyopathy,” Clinical Cardiology, vol. 19, no. 5, pp. 413–418, 1996. View at Scopus
  57. D. P. Dobesh, J. P. Konhilas, and P. P. de Tombe, “Cooperative activation in cardiac muscle: impact of sarcomere length,” American Journal of Physiology, vol. 282, no. 3, pp. H1055–H1062, 2002. View at Scopus
  58. J. C. Kentish, H. E. D. J. ter Keurs, L. Ricciardi, J. J. Bucx, and M. I. Noble, “Comparison between the sarcomere length-force relations of intact and skinned trabeculae from rat right ventricle. Influence of calcium concentrations on these relations,” Circulation Research, vol. 58, no. 6, pp. 755–768, 1986.
  59. D. Burkhoff, S. Sugiura, D. T. Yue, and K. Sagawa, “Contractility-dependent curvilinearity of end-systolic pressure-volume relations,” American Journal of Physiology, vol. 252, no. 6, pp. H1218–H1227, 1987. View at Scopus
  60. D. W. Schwertz, J. M. Beck, J. M. Kowalski, and J. D. Ross, “Sex differences in the response of rat heart ventricle to calcium,” Biological Research for Nursing, vol. 5, no. 4, pp. 286–298, 2004. View at Scopus
  61. S. N. Wang, R. P. Wyeth, and R. H. Kennedy, “Effects of gender on the sensitivity of rat cardiac muscle to extracellular Ca2+,” European Journal of Pharmacology, vol. 361, no. 1, pp. 73–77, 1998. View at Publisher · View at Google Scholar · View at Scopus
  62. C. L. Curl, L. M. D. Delbridge, and I. R. Wendt, “Sex differences in cardiac muscle responsiveness to Ca2+ and L-type Ca2+ channel modulation,” European Journal of Pharmacology, vol. 586, no. 1–3, pp. 288–292, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. B. M. Palmer, Y. Wang, P. Teekakirikul, et al., “Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex,” American Journal of Physiology, vol. 294, no. 4, pp. H1939–H1947, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Thawornkaiwong, J. Pantharanontaga, and J. Wattanapermpool, “Hypersensitivity of myofilament response to Ca2+ in association with maladaptation of estrogen-deficient heart under diabetes complication,” American Journal of Physiology, vol. 292, no. 2, pp. R844–R851, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Wattanapermpool and P. J. Reiser, “Differential effects of ovariectomy on calcium activation of cardiac and soleus myofilaments,” American Journal of Physiology, vol. 277, no. 2, pp. H467–H473, 1999. View at Scopus
  66. J. Wattanapermpool, “Increase in calcium responsiveness of cardiac myofilament activation in ovariectomized rats,” Life Sciences, vol. 63, no. 11, pp. 955–964, 1998. View at Publisher · View at Google Scholar · View at Scopus
  67. C. L. Curl, L. M. D. Delbridge, B. J. Canny, and I. R. Wendt, “Testosterone modulates cardiomyocyte Ca2+ handling and contractile function,” Physiological Research, vol. 58, no. 2, pp. 293–297, 2009. View at Scopus
  68. R. E. Petre, M. P. Quaile, E. I. Rossman, et al., “Sex-based differences in myocardial contractile reserve,” American Journal of Physiology, vol. 292, no. 2, pp. R810–R818, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. R. Dash, K. F. Frank, A. N. Carr, C. S. Moravec, and E. G. Kranias, “Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium,” Journal of Molecular and Cellular Cardiology, vol. 33, no. 7, pp. 1345–1353, 2001. View at Publisher · View at Google Scholar · View at Scopus
  70. N. Leblanc, D. Chartier, H. Gosselin, and J. L. Rouleau, “Age and gender differences in excitation-contraction coupling of the rat ventricle,” Journal of Physiology, vol. 511, no. 2, pp. 533–548, 1998. View at Publisher · View at Google Scholar · View at Scopus
  71. J. A. Wasserstrom, S. Kapur, S. Jones, et al., “Characteristics of intracellular Ca2+ cycling in intact rat heart: a comparison of sex differences,” American Journal of Physiology, vol. 295, no. 5, pp. H1895–H1904, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. N. Hamdani, M. de Waard, A. E. Messer, et al., “Myofilament dysfunction in cardiac disease from mice to men,” Journal of Muscle Research and Cell Motility, vol. 29, no. 6–8, pp. 189–201, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. N. Hamdani, V. Kooij, S. van Dijk, et al., “Sarcomeric dysfunction in heart failure,” Cardiovascular Research, vol. 77, no. 4, pp. 649–658, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. R. J. Solaro, “Multiplex kinase signaling modifies cardiac function at the level of sarcomeric proteins,” Journal of Biological Chemistry, vol. 283, no. 40, pp. 26829–26833, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. S. M. Day, M. V. Westfall, and J. M. Metzger, “Tuning cardiac performance in ischemic heart disease and failure by modulating myofilament function,” Journal of Molecular Medicine, vol. 85, no. 9, pp. 911–921, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. P. P. de Tombe and R. J. Solaro, “Integration of cardiac myofilament activity and regulation with pathways signaling hypertrophy and failure,” Annals of Biomedical Engineering, vol. 28, no. 8, pp. 991–1001, 2000. View at Publisher · View at Google Scholar · View at Scopus
  77. R. J. Solaro, “Control mechanisms regulating contractile activity of cardiac myofilaments,” in Physiology and Pathophysiology of the Heart, N. Sperelakis, Ed., pp. 355–365, Kluwer Academic Publishers, Boston, Mass, USA, 1995.
  78. J. Ross Jr. and B. E. Sobel, “Regulation of cardiac contraction,” Annual Review of Physiology, vol. 34, pp. 47–90, 1972. View at Scopus
  79. W. Luo, I. L. Grupp, J. Harrer, et al., “Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation,” Circulation Research, vol. 75, no. 3, pp. 401–409, 1994. View at Scopus
  80. B. M. Wolska, M. O. Stojanovic, W. Luo, E. G. Kranias, and R. J. Solaro, “Effect of ablation of phospholamban on dynamics of cardiac myocyte contraction and intracellular Ca2+,” American Journal of Physiology, vol. 271, no. 1, pp. C391–C397, 1996. View at Scopus
  81. R. J. Solaro and J. Van Eyk, “Altered interactions among thin filament proteins modulate cardiac function,” Journal of Molecular and Cellular Cardiology, vol. 28, no. 2, pp. 217–230, 1996. View at Publisher · View at Google Scholar · View at Scopus
  82. E. G. Kranias, “Regulation of calcium transport by protein phosphatase activity associated with cardiac sarcoplasmic reticulum,” Journal of Biological Chemistry, vol. 260, no. 20, pp. 11006–11010, 1985. View at Scopus
  83. P. M. L. Janssen and P. P. de Tombe, “Protein kinase A does not alter unloaded velocity of sarcomere shortening in skinned rat cardiac trabeculae,” American Journal of Physiology, vol. 273, no. 5, pp. H2415–H2422, 1997. View at Scopus
  84. J. P. Konhilas, B. M. Wolska, A. F. Martin, R. J. Solaro, and P. P. de Tombe, “PKA modulates length-dependent activation in murine myocardium,” Biophysical Journal, vol. 78, no. 1, p. 108A, 2000.
  85. J. C. Kentish, D. T. McCloskey, J. Layland, et al., “Phosphorylation of troponin I by protein kinase A accelerates relaxation and crossbridge cycle kinetics in mouse ventricular muscle,” Circulation Research, vol. 88, no. 10, pp. 1059–1065, 2001. View at Scopus
  86. Y. Pi, K. R. Kemnitz, D. Zhang, E. G. Kranias, and J. W. Walker, “Phosphorylation of troponin I controls cardiac twitch dynamics: evidence from phosphorylation site mutants expressed on a troponin I-null background in mice,” Circulation Research, vol. 90, no. 6, pp. 649–656, 2002. View at Publisher · View at Google Scholar · View at Scopus
  87. J. L. Garvey, E. G. Kranias, and R. J. Solaro, “Phosphorylation of C-protein, troponin I and phospholamban in isolated rabbit hearts,” Biochemical Journal, vol. 249, no. 3, pp. 709–714, 1988. View at Scopus
  88. R. J. Solaro, A. J. G. Moir, and S. V. Perry, “Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart,” Nature, vol. 262, no. 5569, pp. 615–617, 1976. View at Scopus
  89. N. R. DiPaola, W. E. Sweet, L. B. Stull, G. S. Francis, and C. Schomisch Moravec, “Beta-adrenergic receptors and calcium cycling proteins in non-failing, hypertrophied and failing human hearts: transition from hypertrophy to failure,” Journal of Molecular and Cellular Cardiology, vol. 33, no. 6, pp. 1283–1295, 2001. View at Publisher · View at Google Scholar · View at Scopus
  90. M. Bristow, “Antiadrenergic therapy of chronic heart failure: surprises and new opportunities,” Circulation, vol. 107, no. 8, pp. 1100–1102, 2003. View at Publisher · View at Google Scholar · View at Scopus
  91. Y. E. Koshman, M. R. Piano, B. Russell, and D. W. Schwertz, “Signaling responses after exposure to 5 alpha-dihydrotestosterone or 17 beta-estradiol in norepinephrine-induced hypertrophy of neonatal rat ventricular myocytes,” Journal of Applied Physiology, vol. 108, no. 3, pp. 686–-696, 2010.
  92. K. L. Vikstrom, S. M. Factor, and L. A. Leinwand, “Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy,” Molecular Medicine, vol. 2, no. 5, pp. 556–567, 1996. View at Scopus
  93. A. A. T. Geisterfru-Lowrance, M. Christe, D. A. Conner, et al., “A mouse model of familial hypertrophic cardiomyopathy,” Science, vol. 272, no. 5262, pp. 731–734, 1996. View at Scopus
  94. J. P. Konhilas, P. A. Watson, A. Maass, et al., “Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy,” Circulation Research, vol. 98, no. 4, pp. 540–548, 2006. View at Publisher · View at Google Scholar · View at Scopus
  95. K. Freeman, C. Colon-Rivera, M. C. Olsson, et al., “Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene,” American Journal of Physiology, vol. 280, no. 1, pp. H151–H159, 2001. View at Scopus
  96. M. C. Olsson, B. M. Palmer, L. A. Leinwand, and R. L. Moore, “Gender and aging in a transgenic mouse model of hypertrophic cardiomyopathy,” American Journal of Physiology, vol. 280, no. 3, pp. H1136–H1144, 2001. View at Scopus
  97. M. Spindler, K. W. Saupe, M. E. Christe, et al., “Diastolic dysfunction and altered energetics in the αMHC(403/+) mouse model of familial hypertrophic cardiomyopathy,” Journal of Clinical Investigation, vol. 101, no. 8, pp. 1775–1783, 1998. View at Scopus
  98. D. Georgakopoulos, M. E. Christe, M. Giewat, C. M. Seidman, J. G. Seidman, and D. A. Kass, “The pathogenesis of familial hypertrophic cardiomyopathy: early and evolving effects from an α-cardiac myosin heavy chain missense mutation,” Nature Medicine, vol. 5, no. 3, pp. 327–330, 1999. View at Publisher · View at Google Scholar · View at Scopus
  99. J. S. Ingwall, ATP and the Heart, Kluwer Academic Publishers, Boston, Mass, USA, 2002.
  100. L. Nascimben, J. S. Ingwall, B. H. Lorell, et al., “Mechanisms for increased glycolysis in the hypertrophied rat heart,” Hypertension, vol. 44, no. 5, pp. 662–667, 2004. View at Publisher · View at Google Scholar · View at Scopus
  101. H. Degens, K. F. J. de Brouwer, A. J. Gilde, et al., “Cardiac fatty acid metabolism is preserved in the compensated hypertrophic rat heart,” Basic Research in Cardiology, vol. 101, no. 1, pp. 17–26, 2006. View at Publisher · View at Google Scholar · View at Scopus
  102. P. M. Barger, J. M. Brandt, T. C. Leone, C. J. Weinheimer, and D. P. Kelly, “Deactivation of peroxisome proliferator-activated receptor-α during cardiac hypertrophic growth,” Journal of Clinical Investigation, vol. 105, no. 12, pp. 1723–1730, 2000. View at Scopus
  103. J. C. Osorio, W. C. Stanley, A. Linke, et al., “Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-α in pacing-induced heart failure,” Circulation, vol. 106, no. 5, pp. 606–612, 2002. View at Publisher · View at Google Scholar · View at Scopus
  104. K. K. Kalsi, R. T. Smolenski, R. D. Pritchard, A. Khaghani, A. M. L. Seymour, and M. H. Yacoub, “Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy,” European Journal of Clinical Investigation, vol. 29, no. 6, pp. 469–477, 1999. View at Publisher · View at Google Scholar · View at Scopus
  105. M. N. Sack, D. L. Disch, H. A. Rockman, and D. P. Kelly, “A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 12, pp. 6438–6443, 1997. View at Publisher · View at Google Scholar · View at Scopus
  106. F. Djouadi, C. J. Weinheimer, J. E. Saffitz, et al., “A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor α-deficient mice,” Journal of Clinical Investigation, vol. 102, no. 6, pp. 1083–1091, 1998. View at Scopus
  107. C. Nöhammer, F. Brunner, G. Wölkart, et al., “Myocardial dysfunction and male mortality in peroxisome proliferator-activated receptor alpha knockout mice overexpressing lipoprotein lipase in muscle,” Laboratory Investigation, vol. 83, no. 2, pp. 259–269, 2003. View at Scopus
  108. S. Nielsen, Z. Guo, J. B. Albu, S. Klein, P. C. O'Brien, and M. D. Jensen, “Energy expenditure, sex, and endogenous fuel availability in humans,” Journal of Clinical Investigation, vol. 111, no. 7, pp. 981–988, 2003. View at Publisher · View at Google Scholar · View at Scopus
  109. G. F. Lewis, “Fatty acid regulation of very low density lipoprotein production,” Current Opinion in Lipidology, vol. 8, no. 3, pp. 146–153, 1997. View at Publisher · View at Google Scholar · View at Scopus
  110. F. Magkos, B. W. Patterson, B. S. Mohammed, S. Klein, and B. Mittendorfer, “Women produce fewer but triglyceride-richer very low-density lipoproteins than men,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 4, pp. 1311–1318, 2007. View at Publisher · View at Google Scholar · View at Scopus
  111. S. O. Olofsson and J. Boren, “Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis,” Journal of Internal Medicine, vol. 258, no. 5, pp. 395–410, 2005. View at Publisher · View at Google Scholar · View at Scopus
  112. J. Elovson, J. E. Chatterton, G. T. Bell, et al., “Plasma very low density lipoproteins contain a single molecule of apolipoprotein B,” Journal of Lipid Research, vol. 29, no. 11, pp. 1461–1473, 1988. View at Scopus
  113. R. M. Fisher, S. W. Coppack, S. M. Humphreys, G. F. Gibbons, and K. N. Frayn, “Human triacylglycerol-rich lipoprotein subfractions as substrates for lipoprotein lipase,” Clinica Chimica Acta, vol. 236, no. 1, pp. 7–17, 1995. View at Publisher · View at Google Scholar · View at Scopus
  114. L. L. Spriet, “Regulation of skeletal muscle fat oxidation during exercise in humans,” Medicine and Science in Sports and Exercise, vol. 34, no. 9, pp. 1477–1484, 2002. View at Scopus
  115. R. V. Farese Jr., T. J. Yost, and R. H. Eckel, “Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans,” Metabolism, vol. 40, no. 2, pp. 214–216, 1991. View at Publisher · View at Google Scholar · View at Scopus
  116. J. A. Simoneau, J. H. Veerkamp, L. P. Turcotte, and D. E. Kelley, “Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss,” FASEB Journal, vol. 13, no. 14, pp. 2051–2060, 1999. View at Scopus
  117. E. A. Nikkilä, M. R. Taskinen, S. Rehunen, and M. Härkönen, “Lipoprotein lipase activity in adipose tissue and skeletal muscle of runners: relation to serum lipoproteins,” Metabolism, vol. 27, no. 11, pp. 1661–1667, 1978. View at Scopus
  118. M. Urabe, T. Yamamoto, T. Kashiwagi, et al., “Effect of estrogen replacement therapy on hepatic triglyceride lipase, lipoprotein lipase and lipids including apolipoprotein E in climacteric and elderly women,” Endocrine Journal, vol. 43, no. 6, pp. 737–742, 1996. View at Scopus
  119. T. M. Price, S. N. O'Brien, B. H. Welter, R. George, J. Anandjiwala, and M. Kilgore, “Estrogen regulation of adipose tissue lipoprotein lipase—possible mechanism of body fat distribution,” American Journal of Obstetrics and Gynecology, vol. 178, no. 1, pp. 101–107, 1998. View at Publisher · View at Google Scholar · View at Scopus
  120. H. Homma, H. Kurachi, Y. Nishio, et al., “Estrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter,” Journal of Biological Chemistry, vol. 275, no. 15, pp. 11404–11411, 2000. View at Publisher · View at Google Scholar · View at Scopus
  121. T. P. Flagg, O. Cazorla, M. S. Remedi, et al., “Ca2+-independent alterations in diastolic sarcomere length and relaxation kinetics in a mouse model of lipotoxic diabetic cardiomyopathy,” Circulation Research, vol. 104, no. 1, pp. 95–103, 2009. View at Publisher · View at Google Scholar · View at Scopus
  122. T. E. Haim, W. Wang, T. P. Flagg, et al., “Palmitate attenuates myocardial contractility through augmentation of repolarizing Kv currents,” Journal of Molecular and Cellular Cardiology, vol. 48, no. 2, pp. 395–405, 2010. View at Publisher · View at Google Scholar · View at Scopus
  123. B. N. Finck, J. J. Lehman, T. C. Leone, et al., “The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus,” Journal of Clinical Investigation, vol. 109, no. 1, pp. 121–130, 2002. View at Publisher · View at Google Scholar · View at Scopus
  124. B. N. Finck, X. Han, M. Courtois, et al., “A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 3, pp. 1226–1231, 2003. View at Publisher · View at Google Scholar · View at Scopus
  125. J. A. Paige, R. Liao, R. J. Hajjar, et al., “Effect of a high omega-3 fatty acid diet on cardiac contractile performance in Oncorhynchus mykiss,” Cardiovascular Research, vol. 31, no. 2, pp. 249–262, 1996. View at Publisher · View at Google Scholar · View at Scopus
  126. X. Huang and J. W. Walker, “Myofilament anchoring of protein kinase C-epsilon in cardiac myocytes,” Journal of Cell Science, vol. 117, no. 10, pp. 1971–1978, 2004. View at Publisher · View at Google Scholar · View at Scopus
  127. Y. Pi and J. W. Walker, “Diacylglycerol and fatty acids synergistically increase cardiomyocyte contraction via activation of PKC,” American Journal of Physiology, vol. 279, no. 1, pp. H26–H34, 2000. View at Scopus
  128. N. Szentandrássy, M. R. Pérez-Bido, E. Alonzo, N. Negretti, and S. C. O'neill, “Protein kinase A is activated by the n-3 polyunsaturated fatty acid eicosapentaenoic acid in rat ventricular muscle,” Journal of Physiology, vol. 582, no. 1, pp. 349–358, 2007. View at Publisher · View at Google Scholar · View at Scopus
  129. G. Fragasso, “Inhibition of free fatty acids metabolism as a therapeutic target in patients with heart failure,” International Journal of Clinical Practice, vol. 61, no. 4, pp. 603–610, 2007. View at Publisher · View at Google Scholar · View at Scopus
  130. H. Tuunanen, E. Engblom, A. Naum, et al., “Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure,” Circulation, vol. 114, no. 20, pp. 2130–2137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  131. H. Tuunanen, E. Engblom, A. Naum, et al., “Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction,” Journal of Cardiac Failure, vol. 12, no. 8, pp. 644–652, 2006. View at Publisher · View at Google Scholar · View at Scopus